Additional file 3: of Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
- Elina Urpilainen (5568329)
- Mikko Marttila (5568332)
- Ari Hautakoski (5568335)
- Martti Arffman (3252981)
- Reijo Sund (3252978)
- Pirjo Ilanne-Parikka (263657)
- Reetta Arima (5568338)
- Jenni Kangaskokko (5568341)
- Ulla Puistola (3946178)
- Marianne Hinkula (5568344)
- Esa Läärä (133639)
Publication date
July 2018
DOIAbstract
Label: Estimated HRs (with 95% CIs) of OC death in relation to cumulative use of medications. Fitted curves are cubic splines, with inner knots at 1.5 and 3 years, estimated from a mutually adjusted Cox regression model. OC ovarian cancer, HR hazard ratio, 95% CI 95% confidence interval, DDD defined daily dose. (PDF 251 kb
Add to ORKG